Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Bayliss

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Australian and New Zealand Journal of Medicine|February 1, 1989
Malignant paraganglioma causing bilateral pleural effusionsR M Clarnette, E J Bayliss, L Matz
British Medical Journal (Clinical Research Ed.)|April 20, 1985
Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsS G Allan, E J Bayliss, P S Warrington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Australasian Radiology|August 1, 1996
Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancerJ M Trotter, A J Edis, J B Blackwell, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Australian and New Zealand Journal of Medicine|February 1, 1989
Malignant paraganglioma causing bilateral pleural effusionsR M Clarnette, E J Bayliss, L Matz
British Medical Journal (Clinical Research Ed.)|April 20, 1985
Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsS G Allan, E J Bayliss, P S Warrington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Australasian Radiology|August 1, 1996
Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancerJ M Trotter, A J Edis, J B Blackwell, et al.
Pageof 1